Consumer Defensive
Parag Milk Foods Limited Q2 & H1 FY27: Highest Ever Quarterly Revenue Rs. 1,241 Cr
Parag Milk Foods Limited (PARAGMILK) reports Q2 FY27 revenue of Rs. 1,241 Cr, a 23% YoY increase, driven by strong volume growth.
Parag Milk Foods Limited (PMFL) announced its un-audited financial results for the quarter and half year ended September 30, 2026, marking a significant milestone with the highest-ever quarterly revenue of Rs. 1,241 crore, a robust 23% year-on-year growth. This impressive performance was backed by a 12% volume growth and a 37% year-on-year increase in EBITDA.
Quarterly Highlights
The consolidated financial performance for Q2 FY27 showcased a revenue of Rs. 1,241 crore, with a gross profit of Rs. 323 crore, up 24% YoY. The EBITDA surged by 37% to Rs. 101 crore, contributing to an EBITDA margin of 8.1%. Despite an 8% decline in PAT, the profit after tax grew by 42% excluding last year’s one-off gain of Rs. 16 crore.
Half-Year Performance
For H1 FY27, the revenue stood at Rs. 2,185 crore, reflecting an 8% volume growth and an 18% value growth. The EBITDA increased by 23% to Rs. 170 crore, with an EBITDA margin of 7.8%. The PAT, although showing a 13% decline, grew by 12% excluding the one-off gain from the previous year.
Strategic Investments and Expansion
PMFL is also investing heavily in capacity expansion. The board approved a plan to scale paneer capacity from 20 MT/day to 80 MT/day by June 2027, with an investment of approximately Rs. 100 crore. Additionally, cheese capacity is being doubled from 60 MT/day to 120 MT/day at an investment of Rs. 105 crore, expected to be completed by FY28. These initiatives aim to strengthen the company’s scale and support its shift towards value-added, protein-led offerings.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Parag Milk Foods Limited
Parag Milk Foods Limited belongs to the Consumer Defensive › Packaged Foods sector. Here’s a quick read on where the business and the stock stand today.
Parag rises 23.5% over three months, with buying pressure holding steady. The PEG of 0.77 signals undervaluation relative to growth. It is a potential re-rating candidate. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Buyers show up with 1.6x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. The stock rises 23.5% in three months on 9.6% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Parag Milk Foods Limited.
Consumer Defensive
Zydus Wellness Limited (zyduswell) Q2 FY27: Net Sales Up 74.6%
Zydus Wellness Limited (ZYDUSWELL) reports a 74.6% increase in consolidated net sales for Q2 FY27, reaching ₹11,227 million.
Zydus Wellness Limited (ZYDUSWELL) has reported a consolidated growth of 74.6% in net sales for Q2 FY27, reaching ₹11,227 million compared to ₹6,429 million in the same period last year. The company’s EBITDA for the quarter stood at ₹855 million, marking a growth of 271.7%.
Strong Performance Across Segments
The company’s Skin & Hair Care brands continued to grow, with a 37.5% increase in sales. Everyuth, a leading brand in facial cleansing, maintained double-digit growth and strengthened its market share in scrubs and peel-off categories, holding 50.2% and 75.6% respectively. Sugar Free brand also performed well, entering the Monk Fruit Sweetener category and maintaining a 96% market share in sugar substitutes.
EBITDA and Half-Year Growth
On a half-year basis, Zydus Wellness reported sales of ₹25,526 million, a 70.1% growth over the same period last year. The company’s EBITDA for the first half of the year reached ₹3,272 million, showing an 83.2% increase. This robust performance highlights the company’s strong operational efficiency and market presence.
Notably, brands like RiteBite Max Protein and Complan continued to sustain their growth trajectories, driven by innovation and market demand. As a result, Zydus Wellness Limited (ZYDUSWELL) is well-positioned for continued growth in the upcoming quarters.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Zydus Wellness Limited
Zydus Wellness Limited belongs to the Consumer Defensive › Packaged Foods sector. Here’s a quick read on where the business and the stock stand today.
Zydus falls 12.6% over three months and has not found a floor yet. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. 1 loss quarter(s) over five years signals earnings fragility — not chronic but worth noting. Buyers show up with 3.1x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. The stock rises -12.6% in three months on 20.7% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Zydus Wellness Limited.
ABDL
Allied Blenders and Distillers Limited (abdl) Expands Rangeela Vodka Portfolio with Two New Flavours
Allied Blenders and Distillers Limited (ABDL) introduces two new Rangeela Vodka flavours, Jhatpat Jamun and Kala Khatta, expanding its super-premium portfolio.
Allied Blenders and Distillers Limited (ABDL) has announced the launch of two new flavours in its Rangeela Vodka portfolio: Rangeela Jhatpat Jamun Vodka and Rangeela Kala Khatta Vodka. This expansion marks a significant move by ABDL’s luxury spirits subsidiary, ABD Maestro Private Limited, to tap into the growing consumer interest in homegrown, flavourful spirits.
Innovative Flavours Inspired by Indian Street Food
The new Rangeela Vodka flavours are inspired by the vibrant street food culture of India. Rangeela Jhatpat Jamun Vodka opens with fresh garden mint, followed by the sweet-tart richness of jamun, and a gentle chilli warmth on the finish. On the other hand, Rangeela Kala Khatta Vodka leads with zesty lemon, while tangy tamarind and the sweet-sour, chatpata character unfold on the palate.
Crafted for Modern Social Occasions
Commenting on the launch, Bikram Basu, Vice Chairman of ABD Maestro, said, ‘Rangeela Vodka celebrates India’s vibrant, unapologetic spirit. With Jhatpat Jamun and Kala Khatta, we are tapping into tastes that we instantly connect with, translating street-side love for a flavour into a world-class, super-premium liquid. Triple distilled and platinum chill filtered, these homegrown flavours deliver exceptional craft spirit for modern social occasions.’ Both flavours are available in Maharashtra in 750 ml and 180 ml bottles, priced at ₹2,500 and ₹625 respectively, with Goa, Haryana, and Uttar Pradesh to follow shortly.
This launch underscores ABDL’s continued focus on premiumisation through innovation-led brands, reinforcing its position as a leader in the spirits industry.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Allied Blenders and Distillers Limited
Allied Blenders and Distillers Limited belongs to the Consumer Defensive › Beverages – Wineries & Distilleries sector. Here’s a quick read on where the business and the stock stand today.
Allied gains 21.4% over three months and trades near its 52-week highs. The PEG of 0.23 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Thin margins at 5.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Buyers show up with 2.0x the volume of sellers. Moreover, they dominated on 19 of recent sessions versus 11 for sellers — a healthy accumulation pattern. Both the business and the stock move in the right direction. Revenue grows at 7.4%, profits at 422.6%, and the PEG sits at 0.23 — below its growth rate. That combination is rare. Check Fundamentals of Allied Blenders and Distillers Limited.
Consumer Defensive
Crizac Limited Q2 FY27: Total Income Down 34.5%, Declares ₹4 Interim Dividend
Crizac Limited (CRIZAC) reports Q2 FY27 results with a 34.5% YoY decline in total income, but declares ₹4 interim dividend.
Crizac Limited (CRIZAC) announced its Q2 FY27 results today, revealing a 34.5% year-on-year decline in total income to ₹1,112 million. Despite the drop, the board has declared an interim dividend of ₹4 per equity share, reflecting confidence in the company’s long-term fundamentals.
Financial Performance
Operating EBITDA fell by 44.0% YoY to ₹330 million, with an operating EBITDA margin of 32.2%. The PAT declined by 23.7% YoY to ₹369 million. For H1 FY27, total income was ₹3,196 million, down 17.4% YoY. The operating EBITDA was ₹930 million, with an EBITDA margin of 30.6%. The PAT for H1 FY27 was ₹840 million, down 10.7% YoY.
Market Impact
Dr. Vikash Agarwal, Managing Director of Crizac Limited, noted that Q2 FY27 was shaped by external disruptions to global student mobility, including international travel disruptions and flight cancellations. These factors led to a number of students deferring their plans this year. However, the company expects pent-up demand from students to drive stronger performance in Q3 and Q4 FY27.
Looking Ahead
Crizac Limited remains optimistic about its long-term prospects, anchored by long-standing university partnerships, a robust counselling partner base, and scalable technology. The company is also pursuing targeted acquisitions to broaden its destination presence and offset market pressures.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Crizac Limited
Crizac Limited belongs to the Consumer Defensive › Education & Training Services sector. Here’s a quick read on where the business and the stock stand today.
Crizac drops 25.2% over three months and trades near its 52-week lows. The PEG of 0.22 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. D/E stands at 0.00 with a 9.86% dividend yield. Furthermore, the business records zero revenue dips and zero loss quarters in five years — a fortress balance sheet. RSI stands at 23, well into oversold territory. Yet sellers still dominated on 17 of recent sessions versus 13 for buyers, so the pressure has not fully lifted. Revenue grows at 56.0% and profits at 60.0% CAGR, with D/E of 0.00. Meanwhile, the stock dips 25.2% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Crizac Limited.
-
Industrials3 days agoZen Technologies Limited (zentec) Q2 & H1fy27: Record Revenue and Order Book Growth
-
Consumer Cyclical3 days agoLemon Tree Hotels Limited (lemontree) Elevates its Brand Portfolio in Bengaluru and Hyderabad
-
Advertising Agencies3 days agoAffle 3i Limited Announces Acquisition of Perion to Scale CPCU Business
-
Drug Manufacturers - General3 days agoSai Parenterals Limited Q2 & H1 FY27: Revenue Up 9%, PAT Grows 32.7%
-
COALINDIA3 days agoCoal India Limited (coalindia) Records All-time High Coal Supplies in October FY’27
-
AKUMS2 days agoAkums Drugs and Pharmaceuticals Limited (akums) Q2 FY27: Revenue Up 32%, Ebitda and PAT Surge
-
Information Technology Services2 days agoOrient Technologies Limited (orienttech) Q2 FY27: Strong Profitability on Higher Managed Services Contribution
-
Consumer Cyclical2 days agoTbo Tek Limited (tbotek) Q2 FY27: Revenue Up 53%, Adj. Ebitda at ₹152 Crores